General Archive
-
LifeArc Translational Science Summit on MND and Rare Dementias
About the event The LifeArc Translational Science Summit on MND and Rare Dementias will showcase LifeArc’s innovative work and expert…
-
News releases
Third global Longitude Prize to be launched in 2025 focusing on ALS
A LifeArc-funded prize to incentivise the use of AI and machine-learning approaches in drug discovery for ALS, a form of…
-
MND biomarker roadmap report
LifeArc convened a group of experts from the MND biomarker community for a roundtable event, discussing the challenges holding us…
-
MND Insights report
At LifeArc, we know from experience that for medical research to be most effective, it is vital that the people…
-
MND International Symposium
About the event The International Symposium is the biggest annual conference dedicated to ALS and MND research. Each year it…
-
MND TPP: Guiding the development of MND therapeutics with a target product profile
Guiding the development of MND therapeutics with a target product profile We are establishing a patient-focused target product profile (TPP)…
-
ALS TDI: Advancing ALS/MND prognosis, monitoring, and drug development
ALS TDI: Advancing ALS/MND prognosis, monitoring, and drug development We are collaborating with the ALS Therapy Development Institute (ALS TDI)…
-
MND STaR: Validating therapeutic targets for motor neuron disease with King’s College London
Validating therapeutic targets for motor neuron disease with King’s College London We have teamed up with King’s College London (King’s)…
-
News releases
£76M investment backing into potential MND treatment, underlines benefit of charity funding
Promising new research to develop gene therapy to treat motor neuron disease and other conditions like dementia secures big investment…
-
ALS Therapy Development Institute Summit
About the event The ALS TDI Summit is a free conference that aims to inform and empower the ALS community…
-
News releases
New partnership aims to develop clinical tools for motor neuron disease prognosis, monitoring, and drug development
LifeArc and ALS Therapy Development Institute (ALS TDI) have joined forces to identify, validate, and develop new biomarkers that are…
-
News releases
LifeArc and Kings College London team up to accelerate MND treatment development by driving systematic target validation
LifeArc has pledged £1.5 million to fund a new two-year collaborative partnership with King’s College London (KCL) to validate a…